Systematic review and meta-analysis of the effectiveness of pre-pregnancy care for women with diabetes for improving maternal and perinatal outcomes
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Pre-gestational diabetes mellitus is associated with increased risk of maternal and perinatal adverse outcomes. This systematic review was conducted to evaluate the effectiveness and safety of pre-conception care (PCC) in improving maternal and perinatal outcomes. METHODS: Databases from MEDLINE, EMBASE, WEB OF SCIENCE, and Cochrane Library were searched, including the CENTRAL register of controlled trials, and CINHAL up until March 2019, without any language restrictions, for any pre-pregnancy care aiming at health promotion, glycemic control, and screening and treatment of diabetes complications in women with type I or type II pre-gestational diabetes. Trials and observational studies were included in the review. Newcastle-Ottawa scale and the Cochrane collaboration methodology for data synthesis and analysis were used, along with the GRADE tool to evaluate the body of evidence. RESULTS: The search identified 8500 potentially relevant citations of which 40 reports of 36 studies were included. The meta-analysis results show that PCC reduced congenital malformations risk by 71%, (Risk ratio (RR) 0.29; 95% CI: 0.21-0.40, 25 studies; 5903 women; high-certainty evidence). The results also show that PCC may lower HbA1c in the first trimester of pregnancy by an average of 1.27% (Mean difference (MD) 1.27; 95% CI: 1.33-1.22; 4927 women; 24 studies, moderate-certainty evidence). Furthermore, the results suggest that PCC may lead to a slight reduction in the risk of preterm delivery of 15%, (RR 0.85; 95% CI: 0.73-0.99; nine studies, 2414 women; moderate-certainty evidence). Moreover, PCC may result in risk reduction of perinatal mortality by 54%, (RR 0.46; 95% CI: 0.30-0.73; ten studies; 3071 women; moderate-certainty evidence). There is uncertainty about the effects of PCC on the early booking for antenatal care (MD 1.31; 95% CI: 1.40-1.23; five studies, 1081 women; very low-certainty evidence) and maternal hypoglycemia in the first trimester, (RR 1.38; 95% CI: 1.07-1.79; three studies; 686 women; very low- certainty evidence). In addition, results of the meta-analysis indicate that PCC may lead to 48% reduction in the risk of small for gestational age (SGA) (RR 0.52; 95% CI: 0.37-0.75; six studies, 2261 women; moderate-certainty evidence). PCC may reduce the risk of neonatal admission to intensive care unit (NICU) by 25% (RR 0.75; 95% CI: 0.67-0.84; four studies; 1322 women; moderate-certainty evidence). However, PCC may have little or no effect in reducing the cesarean section rate (RR 1.02; 95% CI: 0.96-1.07; 14 studies; 3641 women; low-certainty evidence); miscarriage rate (RR 0.86; 95% CI: 0.70-1.06; 11 studies; 2698 women; low-certainty evidence); macrosomia rate (RR 1.06; 95% CI: 0.97-1.15; nine studies; 2787 women, low-certainty evidence); neonatal hypoglycemia (RR 0.93; 95% CI: 0.74-1.18; five studies; 880 women; low-certainty evidence); respiratory distress syndrome (RR 0.78; 95% CI: 0.47-1.29; four studies; 466 women; very low-certainty evidence); or shoulder dystocia (RR 0.28; 95% CI: 0.07-1.12; 2 studies; 530 women; very low-certainty evidence). CONCLUSION: PCC for women with pre-gestational type 1 or type 2 diabetes mellitus is effective in improving rates of congenital malformations. In addition, it may improve the risk of preterm delivery and admission to NICU. PCC probably reduces maternal HbA1C in the first trimester of pregnancy, perinatal mortality and SGA. There is uncertainty regarding the effects of PCC on early booking for antenatal care or maternal hypoglycemia during the first trimester of pregnancy. PCC has little or no effect on other maternal and perinatal outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Preconception counseling is also associated with reductions in perinatal mortality and small-for-gestational-age birth weight (18).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Preconception counseling for pregnant people with preexisting type 1 or type 2 diabetes is highly effective in reducing the risk of congenital malformations and decreasing the risk of preterm delivery and admission to neonatal intensive care units.”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The preconception care of people with known preexisting diabetes results in lower A1C and reduced risk of birth defects, preterm delivery, perinatal mortality, small-for-gestational-age birth weight, and neonatal intensive care unit admission (173).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [173]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“as the preconception care of people with preexisting diabetes results in lower A1C and reduced risk of birth defects, preterm delivery, perinatal mortality, small-forgestational-age birth weight, and neonatal intensive care unit admission (188).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [188]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“results from in-school nutrition and lifestyle education programs have been inconsistent.1525–1531”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1528]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · cited 1×
“Additionally, with the increased recognition of the importance of evaluation of the body of evidence a grading tool, Grading of Recommendations Assessment, Development and Evaluation (GRADE), has been introduced to facilitate evidence-based decision making for interventions in clinical medicine and health policy [17].”
MethodEpidemiology and causes of preterm birth
Goldenberg, R. L., Culhane, J. F., Iams, J. D., & Romero, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60074-4 · Cited by 7,801 · cited 1×
“The etiology of preterm birth is complex and many medical, socioeconomic, and psychological factors interplay in the causation of preterm delivery [83].”
Background(1996) · Institutional Research Information System University of Turin (University of Turin) · doi:10.1111/j · Cited by 5,486
An overview of mortality and sequelae of preterm birth from infancy to adulthood
Saigal, S., & Doyle, L. W. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60136-1 · Cited by 2,818 · cited 1×
“leading cause of under-five mortality and one of the main causes of both short and long-term morbidity [85, 86].”
BackgroundChawanpaiboon, S., Vogel, J. P., Moller, A.-B., Lumbiganon, P., Petzold, M., Hogan, D., Landoulsi, S., Jampathong, N., Kongwattanakul, K., Laopaiboon, M., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30451-0 · Cited by 2,572 · cited 1×
“84 million preterm live births were born in the year 2014, with the majority born in low- and middle-income countries [84].”
BackgroundOxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232 · cited 1×
“Evidence from clinical and experimental studies showed that hyperglycemia leads to the production of reactive oxygen species and depletion of antioxidants, which in turn causes intracellular oxidative stress, cell injury and cell death at the time of organogenesis [74, 75].”
BackgroundUnintended pregnancy in the United States: incidence and disparities, 2006
Finer, L. B., & Zolna, M. R. (2011) · Contraception · doi:10.1016/j.contraception.2011.07.013 · Cited by 1,291
Evers, I. M., de Valk, H. W., & Visser, G. H. A. (2004) · BMJ · doi:10.1136/bmj.38043.583160.ee · Cited by 775 · cited 3×
“9 Evers (2004) Netherland [47] PCC: 271 women with (DM-I) NO-PCC: 52 women with (DM-I) PCC included: • Planned pregnancy, • Folic acid supplementation, • Glycemic control.”
BackgroundInfluentialDiabetes in sub-Saharan Africa
Mbanya, J. C. N., Motala, A. A., Sobngwi, E., Assah, F. K., & Enoru, S. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60550-8 · Cited by 775 · cited 1×
“Furthermore, in low and middle-income countries, the burden of diabetes is higher among the younger population, including women in the reproductive age group [2].”
Background
Research works printed but not linked: 7
- 1. International Diabetes Federation. IDF Diabetes Atlas. 8th ed. Brussels, Belgium: IDF. [15 October 2019]. Available from: http://www.diabetesatlas.org.
- 12. National Collaborating Centre for Ws, Children's H. National Institute for Health and Clinical Excellence: Guidance. Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London: RCOG Press. National Collaborating Centre for Women's and Chil- dren's Health.; 2008.
- 18. Wahabi H, Bahkali K, Titi M, Esmaeil S, Amer Y, Fayed A, et al. PROSPERO International prospective register of systematic reviews Preconception care for diabetic women for improving maternal and peri- natal outcomes: a systematic review and meta-analysis2019.
- 20. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane Handbook for Sys- tematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane; [updated July 2019]. Avail- able from: www.training.cochrane.org/handbook.
- 22. GRADEpro GDT: GRADEpro Guideline Development Tool [Software].
- 23. Review manager (RevMan). Copenhagen (Denmark): The Cochrane Collaboration, Nordic Cochrane Centre; 2014.
- 25. Hartling L, Hamm M, A M. Validity and Inter-Rater Reliability Testing of Quality Assessment Instruments US: Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 [18 August 2019]. Avail- able from: https://www.ncbi.nlm.nih.gov/books/NBK92293/
Cited by
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
“perinatal mortality, small-for-gestational-age births, and neonatal intensive care unit admission (208).”
Background2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s015 · Cited by 504
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s002 · Cited by 473
Ornoy, A., Becker, M., Weinstein-Fudim, L., & Ergaz, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062965 · Cited by 339
“They hypothesized that the reduction in SGA infants was due to a reduction in congenital malformations and healthy lifestyle promotion, including smoking cessation, weight control, and avoidance of teratogenic drugs [208].”
Background15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s015 · Cited by 284
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s015 · Cited by 252
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s015 · Cited by 232
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Brown, F. M., ChallaSivaKanaka, S., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s015 · Cited by 176
Munir, H., Yaqoob, S., Awan, K. A., Imtiaz, A., Naveed, H., Ahmad, N., Naeem, M. S., Sultan, W., & Ma, Y. (2024) · Foods · doi:10.3390/foods13111681 · Cited by 121
“Citrus peels include phenolic acids like caffeic, gallic acids, chlorogenic, ferulic, and p-coumaric, which can inhibit α -amylase enzyme functioning [112,284,285].”
BackgroundRisk factors for preterm birth: an umbrella review of meta-analyses of observational studies
Mitrogiannis, I., Εvangelou, Ε., Efthymiou, A., Kanavos, T., Birbas, E., Makrydimas, G., & Papatheodorou, S. (2023) · BMC Medicine · doi:10.1186/s12916-023-03171-4 · Cited by 130
“…after radiotherapy [41] H1 Antihistamine [37] Velamentous cord insertion [42] Metformin [44] Diabetic nephropathy in T1DM [45] Preconception care [47] Asian race [49] Hispanic ethnicity [49] Laparoscopic appendectomy [9] Hyperemesis gravidarum (cohort studies) [54] Hyperemesis gravidarum (case…”
BackgroundMoon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 90
Wyckoff, J., Lapolla, A., Asias-Dinh, B. D., Barbour, L. A., Brown, F. M., Catalano, P. M., Corcoy, R., Renzo, G. C. D., Drobycki, N., Kautzky‐Willer, A., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf288 · Cited by 60
“One potentially undesirable effect of PCC is maternal hypoglycemia in the first trimester, which was evaluated in the meta-analysis of Wahabi et al (5).”
InfluentialFIGO Preconception Checklist: Preconception care for mother and baby
Benedetto, C., Borella, F., Divakar, H., O'Riordan, S. L., Mazzoli, M., Hanson, M. A., O'Reilly, S. L., Jacobsson, B., Conry, J. A., & McAuliffe, F. M. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15446 · Cited by 79
Kang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 85
Piccoli, G. B., Ahmed, S. B., Fakhouri, F., Garovic, V. D., Hladunewich, M., Jesudason, S., Prakash, J., Webster, A. C., Zakharova, E., Cheung, M., et al. (2025) · Kidney International · doi:10.1016/j.kint.2025.02.021 · Cited by 46
Management of type 2 diabetes in pregnancy: a narrative review
Raets, L., Ingelbrecht, A., & Benhalima, K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1193271 · Cited by 33
“However, studies showed a risk reduction of congenital malformations by 71% and reduction of the perinatal mortality risk by 54% (17).”
Albarqi, M. N. (2025) · Healthcare · doi:10.3390/healthcare13091076 · Cited by 73
“A significant body of research, including multiple systematic reviews and meta-analyses, has affirmed prenatal care’s effectiveness in enhancing maternal and neonatal health [12].”
Prepregnancy Counseling Among U.S. Women With Diabetes and Hypertension, 2016–2018
Marshall, C. J., Huma, Z., Deardorff, J., & Britton, L. E. (2021) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.03.021 · Cited by 26
Venkatesh, K. K., Powe, C. E., Buschur, E., Wu, J., Landon, M. B., Gabbe, S. G., Gandhi, K. K., Grobman, W. A., & Fareed, N. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0412 · Cited by 23
Wyckoff, J., Lapolla, A., Asias-Dinh, B. D., Barbour, L. A., Brown, F. M., Catalano, P. M., Corcoy, R., Renzo, G. C. D., Drobycki, N., Kautzky‐Willer, A., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf116 · Cited by 31
Ukoha, W. C., & Mtshali, G. N. (2021) · Healthcare · doi:10.3390/healthcare9111552 · Cited by 27
“Many PCC interventions improved maternal and child outcomes, such as weight loss program, folic acid supplementation, multivitamin, and iron supplementation [14] PCC was proven effective in reducing the rates of congenital malformations and may also improve the risk of preterm delivery in women with type 1 and 2 diabe…”
BackgroundRacial and Socioeconomic Disparities in Preconception Health Risk Factors and Access to Care
Rokicki, S., & McConnell, M. A. (2024) · Journal of Women s Health · doi:10.1089/jwh.2023.0560 · Cited by 18
“59 Systematic reviews have found that some preconception interventions are effective at improving pregnancy outcomes 60,61 ; however, more research on the effectiveness of preconception interventions and policies is needed.”
Prepregnancy Emergency Department Use and Risks of Severe Maternal and Neonatal Morbidity in Canada
Varner, C. E., Park, A. L., & Ray, J. G. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.29532 · Cited by 17
“66) Diseases of genitourinary system (N00-N99) 40 (19-64) 23 833 1.”
BackgroundInfluentialFolate Supplementation in Women with Pre-Existing Diabetes
Perera, N., Rudland, V. L., Simmons, D. S., & Price, S. (2023) · Nutrients · doi:10.3390/nu15081879 · Cited by 17
“Congenital anomalies in women with pre-existing diabetes are largely attributable to maternal hyperglycaemia [78,79].”
BackgroundTreating to Target Glycaemia in Type 2 Diabetes Pregnancy
Yamamoto, J. M., & Murphy, H. R. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220201111200 · Cited by 12
Gomersall, J. S., Moore, V., Fernandez, R. C., Giles, L. C., Grzeskowiak, L. E., Davies, M. J., & Rumbold, A. R. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-082961 · Cited by 17
“In addition to primary prevention, among those with PDMs, preconception care programmes that focus on optimal diabetes management can dramatically reduce the risk of CA. 90 Yet access to preconception care is highly variable, even among women with pre-existing disease.”
BackgroundThe ADIPS Pilot National Diabetes in Pregnancy Benchmarking Programme
Immanuel, J., Flack, J. R., Wong, V., Yuen, L., Eagleton, C. L., Graham, D., Lagstrom, J., Wolmarans, L., Martin, M. B., Cheung, N. W., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18094899 · Cited by 14
“A recent meta-analysis showed a 70% reduction in congenital malformation in women who received preconception care [22].”
MethodEffectiveness of preconception care interventions in primary care: a systematic review protocol
Withanage, N. N., Botfield, J. R., Srinivasan, S., Black, K. I., & Mazza, D. (2022) · BJGP Open · doi:10.3399/bjgpo.2021.0191 · Cited by 14
Negrato, C. A., Marques, P. R., Leite, H. B., Torigoe, C. N., Silva, B. F., Costa, K., Kamei, J. M., Zampa, C. L., Toni, A. C. R. G., Pereira, I. C. G. S., et al. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000521 · Cited by 23
“A meta-analysis that included 25 studies with 5,903 pregnancies showed that preconception care, including improved glycemic control, reduced the risk of congenital malformations by 71.00% (risk ratio 0.29; 95% CI: 0.21-0.40) in children born to women with T1D or type 2 diabetes (T2D) (25).”
BackgroundInfluentialXodo, S., Londero, A. P., D’Agostin, M., Novak, A., Galasso, S., Pittini, C., Baccarini, G., Grimaldi, F., & Driul, L. (2021) · Medicina · doi:10.3390/medicina57050461 · Cited by 12
“meta-analys s nd s stematic review have proved the effectiveness of pre-pregnancy care in reducing congenital malfor ation, perinatal mortality, and lower maternal HbA1c in the firs trimester of pregnancy [18].”
BackgroundMarchincin, S. L., Howley, M. M., Zutphen, A. R. V., Fisher, S. C., Nestoridi, E., Tinker, S. C., Browne, M. L., & Study, N. B. D. P. (2022) · Birth Defects Research · doi:10.1002/bdr2.2050 · Cited by 17
“A meta-analysis of 25 studies demonstrated that preconception care, including glucose monitoring, among women with diabetes reduced their risk of birth defects by 71% (Wahabi et al., 2020).”
Family planning behaviours among women with diabetes mellitus: a scoping review
Dahlan, S. A., Idris, I. B., Nawi, A. M., & Rahman, R. A. (2024) · European journal of medical research · doi:10.1186/s40001-023-01626-1 · Cited by 11
Sabloak, T., Yee, L. M., & Feinglass, J. M. (2023) · Women s Health Reports · doi:10.1089/whr.2023.0072 · Cited by 8
Chimenea, Á., Calderón, A. M., Antiñolo, G., Moreno-Reina, E., & García‐Díaz, L. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111599 · Cited by 8
Looking Back, Visioning Forward: Preconception Health in the US 2005 to 2023
Verbiest, S., Yates, L., Neely, E. J., & Tumblin, C. (2023) · Maternal and Child Health Journal · doi:10.1007/s10995-023-03788-0 · Cited by 9
“(Brown et al., 2017; Dorney et al., 2022; Korenbrot et al., 2002; Shannon et al., 2014; Toivonen et al., 2018; Wahabi et al., 2020) Public health and health care journals have devoted special issues to preconception care.”
Planejamento, metas e monitorização do diabetes durante a gestação
Zajdenverg, L., Façanha, C. F. S., Dualib, P. M., Golbert, A., Negrato, C. A., & Bertoluci, M. C. (2022) · Conectando Pessoas eBooks · doi:10.29327/557753.2022-12 · Cited by 26
Overt diabetes imposes a comparable burden on outcomes as pregestational diabetes: a cohort study
Oppermann, M. L. D. R., Campos, M. A., Hirakata, V. N., & Reichelt, A. J. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00939-1 · Cited by 11
“Preconception care was associated with substantial reduction in rates of congenital malformations and admission to NICU, independent of early prenatal care [15].”
BackgroundPreconception counseling in women with diabetes: the SEARCH for diabetes in youth study
Roberts, A. J., Sauder, K., Stafford, J. M., Malik, F. S., Pihoker, C., Boghossian, N. S., Ehrlich, S., Pettitt, D. J., Dabelea, D., Bellatorre, A., et al. (2023) · Clinical Diabetes · doi:10.2337/cd22-0030 · Cited by 7
Britton, L. E., Arcia, A., Kaur, G., Sontan, O., Marshall, C. J., & George, M. (2023) · Patient Education and Counseling · doi:10.1016/j.pec.2023.107739 · Cited by 8
Toledo‐Chávarri, A., Delgado, J., & Rodríguez‐Martin, B. (2023) · Health Expectations · doi:10.1111/hex.13876 · Cited by 9
“A recent systematic review 11 concluded that preconception care for women with pregestational type 1 or type 2 diabetes mellitus is effective in decreasing congenital malformations, and improving the risk of preterm delivery and admission to the neonatal intensive care unit.”
BackgroundComprehensive Management of Type 2 Diabetes During Pregnancy
Valent, A. M., & Caughey, A. B. (2023) · JAMA · doi:10.1001/jama.2023.0929 · Cited by 9
The limits of preconception care for global health
Waggoner, M. R., & Pentecost, M. (2025) · Sexual and Reproductive Health Matters · doi:10.1080/26410397.2025.2499329 · Cited by 9
“11 However, the bulk of the existing DOHaD evidence base is observational, and the interpretation of this evidence base has frequently been shaped by strong underlying assumptions that maternal factors around the time of pregnancy have a powerful causal role in shaping offspring outcomes.”
Liu, S., Augustin, G., Ning, N., & Ota, E. (2025) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2025.105134 · Cited by 10
Resi, V., Bianchi, C., Burlina, S., Grancini, V., Manicardi, E., Masulli, M., Scarpitta, A. M., Sorice, G. P., & Fresa, R. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02592-2 · Cited by 7
Schoenaker, D. A. J. M., Dyer, E., Heslehurst, N., Kent, G., Gunabalasingam, S., Hopkins, L., Kyrka, A., Lebrett, R., Flynn, A. C., White, S. L., et al. (2025) · Diabetic Medicine · doi:10.1111/dme.70183 · Cited by 9
“73 The review did not identify preconception intervention studies conducted among women with T2D, 73 similar to our more recent review.”
Hicks, R., Dune, T. M., Gu, V., Simmons, D. S., & MacMillan, F. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06951-9 · Cited by 7
“Notably, congenital malformation risks reduced by 71%, lower HbA1c in the first trimester (average − 1.27%), a 15% reduction in pre-term delivery, as well as a reduction in risk of preterm delivery by 54% [3].”
InfluentialGlycaemic control and novel technology management strategies in pregestational diabetes mellitus
Newman, C., Ero, A., & Dunne, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1109825 · Cited by 6
“27% (22)- it is however worth noting that this was in high income countries with homogenous populations.”
BackgroundAung, N. L. (2023) · Clinical Diabetes · doi:10.2337/cd23-0084 · Cited by 7
Adverse pregnancy outcomes in women with type 1 or type 2 diabetes
Simmons, D. S. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30427-7 · Cited by 6
Scott, R., Oliver, N. S., Thomas, M., & Agha-Jaffar, R. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109124 · Cited by 6
Pregnancy outcomes in type 2 versus type 1 diabetes: systematic review with meta-analyses
Drabløs, M., Risstad, H., Alnæs‐Katjavivi, P., & Qvigstad, E. (2023) · Endocrine Connections · doi:10.1530/ec-24-0066 · Cited by 10
“Additionally, older age, more pregestational hypertension, or less access to PPC could negatively impact the risk of preterm birth in women with T2DM (54, 57, 58).”
Gullo, G., Zaami, S., Streva, A. V., Burgio, S., Billone, V., Kotlik, Y., Chitoran, E., Ganduscio, S., Baglìo, G., Perino, A., et al. (2025) · Life · doi:10.3390/life15010048 · Cited by 9
Shub, A. (2020) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13275 · Cited by 5
Risk factors for first-trimester spontaneous abortion and the role of preconception care
Podilyakina, Y., Stabayeva, L., Kulov, D. B., Kamyshanskiy, Y., Туймебаевна, А. Ж., Stundžienė, R., & Zhamantayev, O. (2025) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2025.1615983 · Cited by 12
Gerhardt, C. R., Pulz, G. T. C., Satler, F., & Leitão, C. B. (2023) · Endocrine · doi:10.1007/s12020-023-03344-4 · Cited by 5
“A systematic review with meta-analyses showed that women who received preconception care had better HbA1c compared to those who did not attend this clinic, besides a reduced risk of congenital malformations, preterm birth, and perinatal mortality [33].”
Impact of maternal health on neonatal and long-term kidney outcomes
Kamath, N., Nesargi, S. V., Bajpai, D., Singarayar, P., Vidal, E., & Luyckx, V. A. (2025) · Pediatric Nephrology · doi:10.1007/s00467-025-06771-9 · Cited by 4
“These risks are directly proportional to the blood glucose levels in the pre-conception period, and tight glycemic control is associated with improved outcomes [32].”
FIGO good practice recommendations on preconception care: A strategy to prevent preterm birth
Ojeda, L. I., Cox, G., Buitrago, N. C., Anumba, D. O. C., Gudu, W., Bianchi, A. B., & Jacobsson, B. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70495 · Cited by 11
“35 Recent research has also identified a significant link between thyroid dysfunction and the risk of preterm birth.”
Ikhile, D., Seidu, S., Omodara, D., Katte, J.-C. N., Ramaiya, K. L., & Khunti, K. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00036-7 · Cited by 5
Bizuayehu, H. M., Harris, M. L., Chojenta, C., Forder, P., & Loxton, D. J. (2022) · Midwifery · doi:10.1016/j.midw.2022.103334 · Cited by 5
Malani, K. A., Arbaugh, S., & Bilodeau, C. C. (2024) · Obstetric Medicine · doi:10.1177/1753495x241255812 · Cited by 3
“7 However, many women, particularly women from marginalized racial and ethnic populations and women from lower socioeconomic backgrounds, are less likely to receive prenatal and postpartum care.”
Salih, J. M. (2024) · Intern J Endocrinol Metab · doi:10.5812/ijem-153529 · Cited by 3
“Counseling aims to assess the risk factors, glucose control, associated diseases and complications, remove harmful medications, substitute them with appropriate alternatives, and monitor the pregnancy to reduce complications (9, 10, 22).”
Kodama, S., Fujihara, K., Yagyuda, N., Yachi, Y., Horikawa, C., Takeda, Y., Morikawa, S. Y., Yamada, T., Kato, K., Nakagawa, Y., et al. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/3490884 · Cited by 3
Oppermann, M. L. D. R., Campos, M. A., GUERRA, G. L., Hirakata, V. N., Castanho, V. C., Muck, F. A. L., & Reichelt, A. J. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70369 · Cited by 3
Nofal, A. A., Benkhadra, K., Abbas, A. S., Nduwimana, M.-J., Al-Kordi, M., Allababidi, A. K., Wyckoff, J., Lapolla, A., Prokop, L. J., Wang, Z., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf289 · Cited by 3
Arshadi, M., Lotfi, M. H., Madadizadeh, F., Javaheri, A., & Soodejani, M. T. (2025) · Reproductive Health · doi:10.1186/s12978-025-02180-1 · Cited by 3
GLP-1 Receptor Agonist Use Across Preconception, Pregnancy, and the Postpartum Periods
Porterfield, F., Ogunwole, S. M., Maya, J., & Stanford, F. C. (2026) · Pediatric Drugs · doi:10.1007/s40272-026-00746-5 · Cited by 3
Prenatal monitoring of pregnancies complicated by diabetes mellitus
Macura, M., Dugalić, S., Todorović, J., Gutić, B., Milinčić, M., Božić, D., Stojiljković, M., Micić, J., & Gojnić-Dugalić, M. (2022) · SANAMED · doi:10.5937/sanamed0-40168 · Cited by 3
“In patients with type I diabetes, it is necessary to periodically detect ketonemia and ketonuria with test strips (6).”
BackgroundCampos, M. A., Oppermann, M. L. D. R., Sanseverino, M. T. V., GUERRA, G. L., Hirakata, V. N., & Reichelt, A. J. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01376-y · Cited by 2
“A low frequency of preconception care, evaluated by preconception or early pregnancy folate use, has also been reported in high-income countries [29] and was less than 40% according to a meta-analysis [8].”
BackgroundResultInfluentialYasmeen, Z., Khan, M. A., Masood, A., Akram, M. T., Awan, B., Bhat, M. A., Raza, A., Ahmed, J., Khaliq, S., Al-Omar, M. A., et al. (2025) · Future Medicinal Chemistry · doi:10.1080/17568919.2025.2527619 · Cited by 2
The Challenge of Identifying Causal Pathways Leading to Cerebral Palsy
Hollung, S. J., Vik, T., & Andersen, G. L. (2021) · PEDIATRICS · doi:10.1542/peds.2020-033720 · Cited by 2
Skóra, A., Hajduk-Maślak, K., Galasińska, I., Michalik, B., Szypuła, A., & Sęk, M. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.62.006 · Cited by 3
Lapolla, A., Burlina, S., & Dalfrà, M. G. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01622-4 · Cited by 2
Risk factors for preterm labor: An Umbrella Review of meta-analyses of observational studiesPreprint
Mitrogiannis, I., Εvangelou, Ε., Efthymiou, A., Kanavos, T., Birbas, E., Makrydimas, G., & Papatheodorou, S. (2023) · Research Square · doi:10.21203/rs.3.rs-2639005/v1 · Cited by 2
Reproductive care in Thai women with diabetes mellitus: a descriptive cross-sectional study
Pothongsangarun, K., Li, J., Naeowong, W., Apirakviriya, C., Phutrakool, P., Juntamongkol, T., Sae-chueng, T., Horpratraporn, K., Jaisamrarn, U., & Santibenchakul, S. (2023) · Reproductive Health · doi:10.1186/s12978-023-01694-w · Cited by 1
Pregnancy, risk behaviors and adverse reproductive outcomes: Is preconception care working in Italy?
Bortolus, R., Filippini, F., Cipriani, S., Morassutti, F. R., Marchetto, L., Rigotti, E., Cesari, E., Trevisanuto, D., & Parazzini, F. (2025) · Midwifery · doi:10.1016/j.midw.2025.104404 · Cited by 1
Mishra, S., Semwal, J., Mishra, S. K., & Mirza, N. (2025) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-025-01535-5 · Cited by 2
Utilization of Preconception Care and Associated Factors Among Turkish Women
Demir, Ö., & Yanıkkerem, E. (2025) · Journal of Basic and Clinical Health Sciences · doi:10.30621/jbachs.1393249 · Cited by 1
Hong, S., Lee, K. A., Jung, Y. M., Jeong, H., Sung, J., Seol, H., Seong, W. J., Choi, S. R., Lee, J. H., Kim, S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-24954-0 · Cited by 1
Position Statement on Cardiometabolic Health Across the Woman's Life Course – 2025
de Oliveira, G. M. M., de Almeida, M. C. C., Valério, C. M., Giuffrida, F. M. A., Espíndola, L. N., Izar, M. C. D. O., Marques-Santos, C., Freire, C. M. V., Albuquerque, C. J. D. M., Chagas, A. C. P., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250615i · Cited by 2
Posicionamento sobre a Saúde Cardiometabólica ao Longo do Ciclo de Vida da Mulher – 2025
de Oliveira, G. M. M., de Almeida, M. C. C., Valério, C. M., Giuffrida, F. M. A., Espíndola, L. N., Izar, M. C. D. O., Marques-Santos, C., Freire, C. M. V., Albuquerque, C. J. D. M., Chagas, A. C. P., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250615 · Cited by 5
Position Statement on Cardiometabolic Health Across the Woman's Life Course – 2025
de Oliveira, G. M. M., de Almeida, M. C. C., Valério, C. M., Giuffrida, F. M. A., Espíndola, L. N., Izar, M. C. D. O., Marques-Santos, C., Freire, C. M. V., Albuquerque, C. J. D. M., Chagas, A. C. P., et al. (2025) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2025rbgo200 · Cited by 2
Eddelbuettel, J. C. P., Daw, J. R., Galbraith, A. A., Gordon, S. H., Kaimal, A. J., & Garabedian, L. F. (2025) · Health Affairs · doi:10.1377/hlthaff.2025.00773 · Cited by 3
Meridieth, J., Ehrenberg, S., & Dolin, C. D. (2026) · Physician Assistant Clinics · doi:10.1016/j.cpha.2025.11.005 · Cited by 1
Cohen, D., Nana, M., Hart, N., Arrandale, L., Kelleher, C. J., & Nelson‐Piercy, C. (2026) · Journal of Neurology · doi:10.1007/s00415-026-13629-z · Cited by 1
“PPC is well evidenced to be beneficial for women of child-bearing age with other chronic diseases [7, 8], and leads to better maternal and fetal outcomes.”
Sophiya, K., Kalantri, A., Misra, S., Mundra, A., Kolhe, R., Jakasania, A. H., Mahajan, K., SATHE, H., Patil, B., Raut, A. V., et al. (2026) · BMJ Public Health · doi:10.1136/bmjph-2025-003266 · Cited by 2
Владимировна, М. Е., Yarmolinskaya, M. I., & Tiselko, A. V. (2022) · Journal of obstetrics and women s diseases · doi:10.17816/jowd101090 · Cited by 1
Prepregnancy Management in the Clinical Approach to Diabetes Mellitus
Milionis, C., & Koukkou, E. G. (2022) · Springer eBooks · doi:10.1007/978-3-030-89243-2_10 · Cited by 1
Variations in Author Gender in Obstetrics Disease Prevalence Literature: A Systematic Review
Gálvez, M. R. R., Gallego, B. R., Garcia, M. D. C. S., Gavilán-Cabello, D., Khan, K. S., & Bueno‐Cavanillas, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010727 · Cited by 1
“With the above background, we hypothesized that there is a gender gap in the authorship of worldwide prevalence studies of IPV during pregnancy and GDM [13,14].”
BackgroundOmowunmi, A. K., Muda, S. M., Hasan, H., Ludin, S. M., & Ibrahim, A. F. (2023) · The Malaysian Journal of Nursing · doi:10.31674/mjn.2023.v15i01.006 · Cited by 1
Updates in the Management of Type 1 Diabetes in Pregnancy
Mazori, A. Y., & Levy, C. J. (2024) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2024.05.001 · Cited by 2
Kgosidialwa, O., Bogdanet, D., Egan, A. M., Newman, C., O’Shea, P. M., Biesty, L., McDonagh, C., O'Shea, C., Devane, D., & Dunne, F. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16842 · Cited by 1
Pregestational Diabetes Mellitus
Norwitz, E. R., Saade, G. R., Miller, H. S., & Davidson, C. M. (2016) · Wiley eBooks · doi:10.1002/9781118849897.ch13 · Cited by 1
Dashora, U. K., Ahmed, S., Bossman, I. F., Aung, K. K., Castro, E., & Sathiskumar, P. (2021) · British Journal of Diabetes · doi:10.15277/bjd.2021.287
Type 1 Diabetes in Pregnancy: A Review
Pangkahila, E. S., & Setiawan, W. A. (2022) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2022.4.4.1427 · Cited by 1
Preferred Mode of Delivery among Pregnant Women, A cross Sectional Survey
Khan, K. M. M. F., Khan, N. A., Mumtaz, M. T., Jathol, M., Mahmood, S., & Rashid, K. (2023) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2023174635
Dalfrà, M. G., Burlina, S., Fioretti, M. G., & Lapolla, A. (2024) · Endocrines · doi:10.3390/endocrines5020017
“…care is of key importance in order to reduce maternal and fetal complications in pregnancies that are complicated by pregestational diabetes; thus, the fact that women with overt diabetes do not plan their pregnancies can further explain the high frequency of congenital malformations [25].”
Background
Metadata
- Authors
- Wahabi, H. A., Fayed, A., Esmaeil, S., Elmorshedy, H., Titi, M. A., Amer, Y. S., Alzeidan, R. A., Alodhayani, A. A., Saeed, E., Bahkali, K. H., Kahili-Heede, M. K., Jamal, A., & Sabr, Y.
- Affiliations
- King Saud Medical City (SA)
- Princess Nourah bint Abdulrahman University (SA)
- King Saud University (SA)
- Saudi Center for Disease Prevention and Control (SA)
- University of Hawaiʻi at Mānoa (US)
- Corresponding author
- Fayed, Amel
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-08-18
- Volume
- 15
- Issue
- 8
- Pages
- e0237571
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC7433888
- OpenAlex
- W3062240202
- Cited by
- 130
- References
- 86
- Citations by year
- 2026: 16 · 2025: 42 · 2024: 19 · 2023: 20 · 2022: 18 · 2021: 13 · 2020: 1
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Deanship of Scientific research at Princess Nourah Bint Abdulrahman University (Fast track program)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and Neonatal Healthcare
- Keywords
- preconception care, pregestational diabetes, type 1 diabetes, type 2 diabetes, maternal outcomes, perinatal outcomes, congenital malformations, glycemic control, HbA1c, preterm birth, perinatal mortality, antenatal booking, diabetes screening, diabetes complications, health promotion
- MeSH terms
- Female, Health Promotion, Humans, Infant, Newborn, Pregnancy, Pregnancy in Diabetics, Pregnancy Outcome, Prognosis, Program Evaluation, Preconception Care, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.